New York City, NY -- (SBWIRE) -- 08/14/2013 -- StockMarketIntel.com issues a special report on the following stocks: Las Vegas Railway Express (OTCMKTS:XTRN), Baltia Air Lines Inc (OTCBB:BLTA), Adamis Pharmaceuticals Corp (OTCMKTS:ADMP), Fastfunds Financial Corporation (OTCMKTS:FFFC)
Las Vegas Railway Express (OTCMKTS:XTRN) declined -7.59% recently, while trading on 106,141 shares at the price of $0.0536. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.05 and was moved to its maximum level of $0.21.The stock changed hands in a range of $0.05to $0.06, bringing its market capitalization at about $7.08 million. Las Vegas Railway Express, Inc. focuses on re-establishing a conventional rail passenger train service between Las Vegas and Los Angeles using existing freight railroad lines. It intends to operate a single travel route primarily for a leisure traveler from the Southern California basin. The company is headquartered in Las Vegas, Nevada.
Will XTRN Get Buyers Even After The Recent Rally? Find Out Here
Baltia Air Lines Inc (OTCBB:BLTA) added 4.48% recently, in the current trading session, at $0.0210 with a total volume of 459,000shares. The stock, on average, trades on a volume of 570,143 shares. In the past 52 weeks, the share price has not declined below $0.01 and above $0.04.It floated in a range of $0.02 to $0.02 during the recent trading session, with a beta value of 1.46.Its market capitalization now moved to about $50.52 million. Baltia Air Lines, Inc., a development stage company, intends to offer scheduled air, passenger, cargo, and mail transportation services. It focuses on providing its services from the United States to the Russian Federation, as well as to the former Soviet Union countries; and a non-stop service from New York to St. Petersburg. The company was founded in 1989 and is headquartered in Jamaica, New York.
What was the Moving Force behind BLTA on Bullish Run? Read This Research Report
Adamis Pharmaceuticals Corp (OTCMKTS:ADMP) recently recorded a fall of -6.90% and was moving within a range of $0.50-$0.58. Its current trading price is $0.540. The share price hit its 52-week low of $0.34 and $1.10 was the best price. The stock completed the day with a total volume of 102,755 shares, versus an average volume of 100,602 shares. Adamis Pharmaceuticals Corporation, a biopharmaceutical company, engages in the development and commercialization of specialty pharmaceutical products in the therapeutic areas of oncology, immunology and infectious diseases, and allergy and respiratory.
Will ADMP Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Fastfunds Financial Corporation (OTCMKTS:FFFC) added 36.36% in its current trading activity, bringing its market capitalization around $461,770. The total number of shares that changed hands during the current session up till now was 4.08 million shares, as compared to average trading volume of 3.49 million shares. The share price after opening at $0.002, made a high of $0.003 and hovered above $0.002, while its recent trading price was $0.0030. FastFunds Financial Corp., through its subsidiary, Advanced Technology Development, Inc., holds a license related to a provisional patent titled, ?METHOD OF SEPARATING CARBON DIOXIDE?. The company?s patent is related to methods of decomposing a gaseous medium, primarily relating to methods of utilizing radio frequency energy to separate the elemental components of gases, such as carbon dioxide.
For How Long FFFC will fight for Profitability? Read This Trend Analysis report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)